The Effectiveness of Chemotherapy in the Treatment of Patients with Breast Cancer
Keywords:
Chemotherapy, surgery, breast cancer, treatment efficacy, drug doses, metastasis patterns
Abstract
Chemotherapy is one of the main treatments for breast cancer. It involves the introduction into the body of drugs that destroy cancer cells and block their growth. In the first three stages, the technique is used in combination with a radical operation. At the fourth stage, radical operations are not performed, and chemotherapy becomes one of the main methods for controlling the tumor and its metastases.
References
1. Stenina M.B., Zhukova L.G., Koroleva I.A., and co-authors /Practical recommendations for the drug treatment of invasive breast cancer// Malignant tumors; 2016, No. 4. Special issue 2.
2. Imyanitov, E.N. Hereditary breast cancer / E.N. Imyanitov // Practical Oncology.-2010.-vol.11.-№4.- р. 258-264.
3. Project. Clinical protocols for the diagnosis and treatment of malignant neoplasms. Association of Oncologists of Russia. Moscow. 2012. Part 2. [Electronic resource] URL: http://www.oncology.ru/service/organization/2012_protocol_chat_second.pdf (Date of access: 05/22/2018)
4. Coates A.S., Winer E.P., Goldhirsch A., et al. /Tailoring therapies -improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015// Annals of Oncology 26, 2015.
5. Cortazar P., Zhang L., Untch M., et al. /Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis// Lancet; 2014.
6. Liedtke C., Mazouni C., Hess K.R., et al. /Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer// J Clin. Oncol. 2008; 26.
7. Masuda H., Baggerly K.A., Wang Y., et al. /Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes// Clin. Cancer Res.; 2013; 19.
2. Imyanitov, E.N. Hereditary breast cancer / E.N. Imyanitov // Practical Oncology.-2010.-vol.11.-№4.- р. 258-264.
3. Project. Clinical protocols for the diagnosis and treatment of malignant neoplasms. Association of Oncologists of Russia. Moscow. 2012. Part 2. [Electronic resource] URL: http://www.oncology.ru/service/organization/2012_protocol_chat_second.pdf (Date of access: 05/22/2018)
4. Coates A.S., Winer E.P., Goldhirsch A., et al. /Tailoring therapies -improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015// Annals of Oncology 26, 2015.
5. Cortazar P., Zhang L., Untch M., et al. /Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis// Lancet; 2014.
6. Liedtke C., Mazouni C., Hess K.R., et al. /Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer// J Clin. Oncol. 2008; 26.
7. Masuda H., Baggerly K.A., Wang Y., et al. /Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes// Clin. Cancer Res.; 2013; 19.
Published
2022-10-12
How to Cite
Feruza, M. (2022). The Effectiveness of Chemotherapy in the Treatment of Patients with Breast Cancer. Central Asian Journal of Medical and Natural Science, 3(5), 294-298. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1092
Section
Articles
